Kiromic BioPharma, Inc.

KRBP · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$26,898-$20,949-$34,731-$25,589
Dep. & Amort.$2,234$2,221$1,673$470
Deferred Tax$0$0$0$0
Stock-Based Comp.$597$141$1,237$3,763
Change in WC$198-$3,213$4,370$710
Other Non-Cash$4,411$575$3,705$324
Operating Cash Flow-$19,458-$21,225-$23,746-$20,322
Investing Activities
PP&E Inv.-$366-$207-$4,881-$1,895
Net Acquisitions$0$0$15$84
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$15-$372
Investing Cash Flow-$366-$207-$4,866-$1,811
Financing Activities
Debt Repay.$0$23,443$4,103$92
Stock Issued$0$659$0$40,000
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$18,415-$111-$200-$2,757
Financing Cash Flow$18,415$23,991$3,903$37,336
Forex Effect$0$0$0$0
Net Chg. in Cash-$1,409$2,559-$24,709$15,203
Supplemental Information
Beg. Cash$3,204$645$25,354$10,151
End Cash$1,795$3,204$645$25,354
Free Cash Flow-$19,824-$21,432-$28,626-$22,216